China Biologic Products Holdings Inc – NASDAQ:CBPO

China Biologic Products Holdings stock price today

$119.99
Financial Health
0
1
2
3
4
5
6
7
8
9

China Biologic Products Holdings stock price monthly change

+1.82%
month

China Biologic Products Holdings stock price quarterly change

+1.27%
quarter

China Biologic Products Holdings stock price yearly change

+10.59%
year

China Biologic Products Holdings key metrics

Market Cap
37.06M
Enterprise value
N/A
P/E
N/A
EV/Sales
N/A
EV/EBITDA
N/A
Price/Sales
N/A
Price/Book
N/A
PEG ratio
N/A
EPS
3.95
Revenue
524.36M
EBITDA
215.54M
Income
152.28M
Revenue Q/Q
9.75%
Revenue Y/Y
4.09%
Profit margin
29.04%
Oper. margin
37.26%
Gross margin
65.68%
EBIT margin
37.26%
EBITDA margin
41.11%
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

China Biologic Products Holdings stock price history

China Biologic Products Holdings stock forecast

China Biologic Products Holdings financial statements

China Biologic Products Holdings Inc (NASDAQ:CBPO): Profit margin
Mar 2020 162.59M 53.38M 32.83%
Jun 2020 111.11M 35.68M 32.11%
Sep 2020 138.53M 39.54M 28.54%
Dec 2020 112.12M 23.67M 21.11%
China Biologic Products Holdings Inc (NASDAQ:CBPO): Earnings per share (EPS)
2020-05-20 1.38 1.56
2020-08-17 1.28 1.11
2020-11-24 1.28 1.39
2021-03-29 0.69 0.91
China Biologic Products Holdings Inc (NASDAQ:CBPO): Debt to assets
Mar 2020 1984725699 174.25M 8.78%
Jun 2020 2024424491 165.33M 8.17%
Sep 2020 2139512852 163.82M 7.66%
Dec 2020 2259514231 177.73M 7.87%
China Biologic Products Holdings Inc (NASDAQ:CBPO): Cash Flow
Mar 2020 75.74M -113.44M 0
Jun 2020 59.72M 369.49M -7.00M
Sep 2020 53.02M -27.76M -4.98M
Dec 2020 69.98M 34.72M -81.02K

China Biologic Products Holdings other data

China Biologic Products Holdings Inc (NASDAQ:CBPO): Insider trades (number of shares)
Period Buy Sel
Jun 2016 0 5550000
Aug 2016 0 54694
Feb 2017 0 62604
Mar 2017 0 74049
May 2017 0 7500
Transaction Date Insider Security Shares Price per share Total value Source
Option
LIU ZHIJING CBPO officer: Corporate Vice President
Stock Option (right to buy) 1,142 $115.4 $131,787
Sale
LIU ZHIJING CBPO officer: Corporate Vice President
Common Stock 1,142 $115.4 $131,787
Option
LIU ZHIJING CBPO officer: Corporate Vice President
Common Stock 1,142 $115.4 $131,787
Option
LIU ZHIJING CBPO officer: Corporate Vice President
Stock Option (right to buy) 6,358 $9.85 $62,626
Sale
LIU ZHIJING CBPO officer: Corporate Vice President
Common Stock 6,358 $9.85 $62,626
Option
LIU ZHIJING CBPO officer: Corporate Vice President
Common Stock 6,358 $9.85 $62,626
Sale
SHAO SEAN director
Common Stock 16,000 $100.8 $1,612,800
Sale
GAO DAVID director, officer: Chief Execut..
Common Stock 54,049 $100.57 $5,435,708
Sale
SHAO SEAN director
Common Stock 4,000 $100.7 $402,800
Sale
GAO DAVID director, officer: Chief Execut..
Common Stock 62,604 $100.69 $6,303,597
  • What's the price of China Biologic Products Holdings stock today?

    One share of China Biologic Products Holdings stock can currently be purchased for approximately $119.99.

  • When is China Biologic Products Holdings's next earnings date?

    Unfortunately, China Biologic Products Holdings's (CBPO) next earnings date is currently unknown.

  • Does China Biologic Products Holdings pay dividends?

    No, China Biologic Products Holdings does not pay dividends.

  • How much money does China Biologic Products Holdings make?

    China Biologic Products Holdings has a market capitalization of 37.06M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 4.09% to 524.37M US dollars. China Biologic Products Holdings earned 152.29M US dollars in net income (profit) last year or $0.91 on an earnings per share basis.

  • What is China Biologic Products Holdings's stock symbol?

    China Biologic Products Holdings Inc is traded on the NASDAQ under the ticker symbol "CBPO".

  • What is China Biologic Products Holdings's primary industry?

    Company operates in the Healthcare sector and Biotechnology industry.

  • How do i buy shares of China Biologic Products Holdings?

    Shares of China Biologic Products Holdings can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • How many employees does China Biologic Products Holdings have?

    China Biologic Products Holdings Inc employs 2,246 workers.

  • When China Biologic Products Holdings went public?

    China Biologic Products Holdings Inc is publicly traded company for more then 19 years since IPO on 24 Jul 2006.

  • What is China Biologic Products Holdings's official website?

    The official website for China Biologic Products Holdings is chinabiologic.com.

  • How can i contact China Biologic Products Holdings?

    China Biologic Products Holdings can be reached via phone at +86 10 6598 3111.

China Biologic Products Holdings company profile:

China Biologic Products Holdings Inc

chinabiologic.com
Exchange:

NASDAQ

Full time employees:

2,246

Industry:

Biotechnology

Sector:

Healthcare

China Biologic Products Holdings, Inc. engages in the research, development, manufacture, and sale of human plasma-based biopharmaceutical products to hospitals and inoculation centers in the People's Republic of China. It offers human albumin for treating shock caused by blood loss trauma or burn; raised intracranial pressure caused by hydrocephalus or trauma; oedema or ascites caused by hepatocirrhosis and nephropathy; and neonatal hyperbilirubinemia, as well as for the prevention and treatment of low-density-lipoproteinemia. The company also provides human immunoglobulin and IVIG for original and secondary immunoglobulin deficiency, auto-immune deficiency, and immunoglobulin G secondary deficiency; human hepatitis B immunoglobulin for the prevention of measles and contagious hepatitis; human rabies immunoglobulin primarily for passive immunity from bites or claws by rabies or other infected animals; and human tetanus immunoglobulin for the prevention and therapy of tetanus. In addition, it offers placenta polypeptide for the treatment of cell immunity deficiency diseases, viral infection, and leucopenia, as well as assists in postoperative healing; factor VIII for treating coagulopathies; human fibrinogen; and human prothrombin complex concentrate for treating congenital and acquired clotting factor II, VII, IX, X deficiency, as well as excessive anticoagulant, vitamin K deficiency, etc. Further, the company is developing Human fibrinogen for the treatment for lack of fibrinogen and increase human fibrinogen concentration; and artificial dura and spinal dura mater products for use in brain and spinal surgeries. The company sells its products directly, as well as through distributors. The company was formerly known as China Biologic Products, Inc. and changed its name to China Biologic Products Holdings, Inc. in July 2017. China Biologic Products Holdings, Inc. is headquartered in Beijing, the People's Republic of China.


Beijing, BEIJING 100125

CIK: 0001369868
ISIN: KYG215151047
CUSIP: G21515104